The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: A cross-sectional sero-epidemiological study-Reference-Cited by-同舟云学术

The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: A cross-sectional sero-epidemiological study

Published:2022-11 Issue:48 Volume:40 Page:6956-6962
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

He Hanqing,Zhu Yao,Jin Mingjuan,Zhou Yang,Tang Xuewen,Yan Rui,Deng Xuan,Chen Kun

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference42 articles.

1. Bordetella pertussis;Nieves;Microbiol Spectrum,2016

2. Burden of Pertussis in Individuals with a Diagnosis of Asthma: A Retrospective Database Study in England;Bhavsar;J Asthma Allergy,2022

3. Burden of Pertussis in COPD: A Retrospective Database Study in England;Aris;COPD,2021

4. Pertussis[EB/OL]. [2022-7-23]. https://www.who.int/health-topics/pertussis#tab=tab_2.

5. Pertussis vaccination in Chinese children with increasing reported pertussis cases;Zhang;Lancet Infect Dis,2022

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the impact of COVID-19 non-pharmaceutical interventions and relaxation policies on Class B respiratory infectious diseases transmission in China;Scientific Reports;2024-09-11

2. Bordetella pertussis infection following relaxation of COVID-19 non-pharmaceutical interventions in 2021–2023 in Vancouver metropolitan area, British Columbia, Canada;Vaccine;2024-09

3. Resurgence of pertussis: reasons and coping strategies;World Journal of Pediatrics;2024-07

4. Seroepidemiology of pertussis in Huzhou: A population-based, cross-sectional study;PLOS ONE;2024-05-20

5. Seroprevalence of IgG antibodies against pertussis toxin in the Chinese population: A systematic review and meta-analysis;Human Vaccines & Immunotherapeutics;2024-05-02